About Wyeth
Wyeth Australia is an important part of a global company that brings healthcare and pharmaceutical products to the people who need them, wherever they are in the world.
Wyeth employs more than 52,000 people worldwide, operating manufacturing facilities on six continents and conducting business in more than 140 countries.
Our focus
Wyeth works in the area of biotechnology and vaccines, as well as traditional pharmaceutical and over-the-counter medicines. We have a particular focus on researching and developing new treatments for conditions such as Rheumatoid Arthritis, Haemophilia, transplantation, depression and the prevention of serious infectious disease like the deadly pneumococcal.
Our record
Last year alone, Wyeth Australia:
- Protected 600,000 babies and children against the deadly pneumococcal disease
- Supported the health and wellbeing of approximately 180,000 patents living with mental illness
- Enabled more than 600 organ transplant recipients to live full and healthy lives
- Supported the nutritional needs of 140,000 babies
- Provided support and options for almost 600,000 women through the provision of oral contraceptives and hormone therapies.
- Continued to be one of the few pharmaceutical companies investing in research and development in the area of infectious disease and antibiotic resistance
